[1] |
Daugaard M, Rohde M, Jäättelä M. The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions. FEBS Lett, 2007, 581(19):3702-3710.
|
[2] |
Pierzchalski P, Krawiec A, Gawelko J, et al. Molecular mechanism of protection against chemically and gamma-radiation induced apoptosis in human colon cancer cells. J Physiol Pharmacol, 2008, 59(Suppl 2):191-202.
|
[3] |
Cardoso F, Di Leo A, Larsimont D, et al. Evaluation of HER2, p53, bcl-2, topoisomerase Ⅱ-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes. Ann Oncol, 2001, 12(5):615-620.
|
[4] |
Nylandsted J, Brand K, Jäättelä M. Heat shock protein 70 is required for the survival of cancer cells. Ann N Y Acad Sci, 2000, 926:122-125.
|
[5] |
Jung KH, Choi MJ, Hong S, et al. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway. Cancer Lett, 2012, 316(2):187-195.
|
[6] |
Sobin LH, Gospondarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th ed. New York: Wiley-Blackwell, 2009: 73-77.
|
[7] |
Zhou Q, Lui VW, Yeo W. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Future Oncol, 2011, 7(10):1149-1167.
|
[8] |
李航宇,孔凡民,董明,等. HSP70和JNK信号转导通路在肝癌组织中的表达及意义.中国组织化学与细胞化学杂志, 2006, 15(3):240-245.
|
[9] |
Sung SY, Chung LW. Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting. Differentiation, 2002, 70(9/10):506-521.
|
[10] |
Swartz MA, Iida N, Roberts EW, et al. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res, 2012, 72(10):2473-2480.
|
[11] |
Li H, Sui C, Kong F, et al. Expression of HSP70 and JNK-related proteins in human liver cancer: potential effects on clinical outcome. Dig Liver Dis, 2007, 39(7):663-670.
|
[12] |
Hu W, Wu W, Yeung SC, et al. Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor. Anticancer Res, 2002, 22(2A):665-672.
|
[13] |
Prasad R, Vaid M, Katiyar SK. Grape proanthocyanidin inhibit pancreatic cancer cell growth in vitro and in vivo through induction of apoptosis and by targeting the PI3K/Akt pathway. PLoS One, 2012, 7(8):e43064.
|
[14] |
Sithanandam G, Smith GT, Masuda A, et al. Cell cycle activation in lung adenocarcinoma cells by the ErbB3/phosphatidylinositol 3-kinase/Akt pathway. Carcinogenesis, 2003, 24(10):1581-1592.
|
[15] |
孙晓杰,黄常志. PI3K-Akt信号通路与肿瘤.世界华人消化杂志, 2006, 14(3):306-311.
|
[16] |
Cheng JC, Chou CH, Kuo ML, et al. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene, 2006, 25(53):7009-7018.
|
[17] |
Wang H, Liu H, Chen K, et al. SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling. Oncol Rep, 2012, 28(1):311-318.
|
[18] |
Soond DR, Slack EC, Garden OA, et al. Does the PI3K pathway promote or antagonize regulatory T cell development and function? Front Immunol, 2012, DOI: 10.3389/fimmu.2012.00244[Epub ahead of print].
|
[19] |
Namiecińska M, Marciniak K, Nowak JZ. VEGF as an angiogenic, neurotrophic, and neuroprotective factor. Postepy Hig Med Dosw (波兰文), 2005, 59:573-583.
|
[20] |
Bruce D, Tan PH. Vascular endothelial growth factor receptors and the therapeutic targeting of angiogenesis in cancer: where do we go from here? Cell Commun Adhes, 2011, 18(5):85-103.
|
[21] |
Ping YF, Yao XH, Jiang JY, et al. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. J Pathol, 2011, 224(3):344-354.
|
[22] |
Yokoyama Y, Mori S, Hamada Y, et al. Platelet-derived growth factor regulates breast cancer progression via β-catenin expression. Pathobiology, 2011, 78(5):253-260.
|
[23] |
Setia S, Sanyal SN. Downregulation of NF-κB and PCNA in the regulatory pathways of apoptosis by cyclooxygenase-2 inhibitors in experimental lung cancer. Mol Cell Biochem, 2012, 369(1/2):75-86.
|
[24] |
Thiel A, Mrena J, Ristimäki A. Cyclooxygenase-2 and gastric cancer. Cancer Metastasis Rev, 2011, 30(3/4):387-395.
|
[25] |
Suzuki Y, Toquenaga Y. Effects of information and group structure on evolution of altruism: analysis of two-score model by covariance and contextual analyses. J Theor Biol, 2005, 232(2):191-201.
|